Navigation Links
Sunridge Advances its PNT Glaucoma Treatment Throughout China
Date:10/7/2010

FOUNTAIN HILLS, Ariz., Oct. 7 /PRNewswire/ -- Sunridge International (OTC Bulletin Board: SNDZ) said today that its patented Pneumatic Trabeculoplasty (PNT) non-invasive treatment for glaucoma and ocular hypertension, is making its mark in China.  Introduced into China by Beijing Vision World Trading Co. Ltd. (BVW), in 2007, the PNT treatment has undergone the most vigorous patient research studies before gaining regulatory approval by China's Federal Drug Administration earlier this year.

In recent months, Beijing Vision World had presented the PNT treatment at a number of ophthalmologist conferences, expert forums and hospital training seminars in a number of cities throughout China including Beijing, Nanjing, Taiyuan, Wuhan, Changsha and several towns throughout Northeast China. Research papers devoted to PNT have been presented by leading ophthalmic practitioners and academics at several conferences all of which have been reported in news articles and feature stories appearing in China's general and technical publications.  Details of the treatment and its impact on glaucoma patients, have been featured on national TV programs.  More information regarding these events can be viewed at www.visionworld.com.cn.

In summarizing his firm's progress, Mr. Yang Waisheng, President of BVW, said he and his marketing team were extremely pleased with the reception given by some of China's most demanding ophthalmologists, eye doctors and hospitals throughout China. "We have made a very good start and it is our intention to continue to demonstrate the PNT approach to the treatment of glaucoma.  Our goal is to have PNT taken up by an increasing number of hospitals, clinics and ophthalmic surgeries in China so that we might reach out to as many glaucoma sufferers as possible throughout this vast country.  We are conscious of the fact that many of these patients would otherwise be unable to find treatment to control this pervasive eye disease which is so prevalent in China."

G. Richard Smith, CEO of Sunridge International, said that China represents an enormous marketing opportunity for the PNT equipment and treatment.  "We are delighted with the progress and sales made by Mr. Yang and his team each month and we are determined to provide maximum sales and marketing support to bear on their efforts to bringing our treatment to the tremendous number of outlets in China."CONTACT:Jeff Smith, Sunridge International  T:  +1-480-837-6165e-mail: info@sunridgeint.comwebsite: www.sunridgeint.comMEDIA:Victor Webb, Marston Webb InternationalT: (212) 684-6601e-mail: marwebint@cs.com
'/>"/>

SOURCE Sunridge International
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Sunridge Announces Marketing Roll Out of PNT in the Dominican Republic
2. Sunridge Schedules European Meetings
3. Sunridge Ships First Order to the Middle East
4. Sunridge to Introduce Their PNT Treatment for Glaucoma to Medical Personnel in India
5. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
6. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
7. Avicena Scientific Collaborator Advances Program for Using Energy Enhancing Molecules to Treat Neuromuscular Diseases
8. Groundbreaking Study Proves Personalized Diet Based on Genetics Leads to Significant Advances in Long Term Weight Management and Blood Glucose Levels
9. Thermo Fisher Scientific Advances Gene-Silencing Technology for Life Sciences Research
10. Stem Cell Breakthrough Advances Science Without Ethical Landmines, Says Cardinal
11. Financial Results for Full Year 2007: NicOx Significantly Advances Clinical Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ... the development of oral drug delivery systems, announced today that ... presented by Joseph Gunnar & Co. LLC, taking ... . Nadav Kidron , CEO of Oramed, will ... Presentation Details:   PIONEERS 2016, presented by ...
(Date:4/27/2016)... 27, 2016  Hologic, Inc. (Nasdaq: ... for the fiscal second quarter ended March 26, ... $0.24 increased 41.2%, and non-GAAP diluted EPS of ... 5.8% on a reported basis, and 6.3% on ... posted another good quarter, highlighted by 14.6% growth ...
(Date:4/27/2016)... New York , April 27, 2016 ... market report titled, "Skincare Devices Market - Global Industry ... 2023." According to the report, the global skincare devices ... and is anticipated to expand at a CAGR of ... Mn in 2023. Browse the full Skincare Devices ...
Breaking Medicine Technology:
(Date:4/29/2016)... ... April 30, 2016 , ... World Patent ... Pick Up Springboard, an automotive invention that improves the storage features of a ... $162 billion," says Scott Cooper, CEO and Creative Director of World Patent Marketing. ...
(Date:4/29/2016)... , ... April 29, 2016 , ... In an ... and divorcee, shares her enthusiasm for Botox and lip injections, which she underwent in ... youth oriented Coachella Valley Music and Arts Festival. The article explains that Ms. Mirmelli’s ...
(Date:4/29/2016)... ... April 29, 2016 , ... Memorial Healthcare ... Graduate Medical Education (ACGME) that it has received accreditation for its residency program ... three residency programs that Memorial is currently pursuing, including Pediatrics and Internal Medicine. ...
(Date:4/29/2016)... ... April 29, 2016 , ... Our bodies are bombarded daily by ... and deal with these stressors is to adopt a more healthful diet, but too ... Risa Groux, a certified Holistic Nutritionist and the creator of the Newport Beach Cleanse ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... our nation’s productivity, stability, even security. Most importantly, employees are the single most ... why are American workers so unhappy? , Just under half of American workers ...
Breaking Medicine News(10 mins):